Treatment of Polymicrobial Infection with Anaerococcus, Gleimia europaea, and Staphylococcus hominis
For this polymicrobial infection involving anaerobes (Anaerococcus species, Gleimia europaea) and a coagulase-negative Staphylococcus, treat with amoxicillin-clavulanate 875/125 mg twice daily orally for outpatient management, or ampicillin-sulbactam 1.5-3.0 g every 6-8 hours IV for severe infections requiring hospitalization.
Rationale and Clinical Approach
This is a polymicrobial infection requiring coverage of both anaerobic organisms and gram-positive cocci. The key organisms here are:
- Anaerococcus species: An anaerobic gram-positive coccus requiring anaerobic coverage
- Gleimia europaea: A recently reclassified organism (formerly Actinomyces europaeus) that has emerging recognition in necrotizing fasciitis and skin abscesses 1
- Staphylococcus hominis (scanty): A coagulase-negative Staphylococcus that, while typically considered a contaminant, can cause true infection particularly in the setting of prosthetic material or surgical sites 2
Antimicrobial Selection
The most effective antimicrobials against anaerobic organisms include metronidazole, carbapenems, beta-lactam/beta-lactamase inhibitor combinations, chloramphenicol, tigecycline, and clindamycin 3, 4, 5. However, since this is a polymicrobial infection with both anaerobes and gram-positive cocci, single-agent therapy covering both pathogens is preferred 6.
First-Line Options:
For outpatient/mild-moderate infections:
- Amoxicillin-clavulanate provides excellent coverage of both anaerobes and staphylococci 7
For severe/hospitalized infections:
- Ampicillin-sulbactam 1.5-3.0 g IV every 6-8 hours 7
- Piperacillin-tazobactam 3.37 g IV every 6-8 hours 7
- Carbapenems (imipenem, meropenem, or ertapenem) 7, 5
Important Caveats:
⚠️ Beta-lactam/beta-lactamase inhibitor combinations miss MRSA 7. If there is clinical concern for MRSA (purulent drainage, prior MRSA history, high local prevalence), add vancomycin or use alternative coverage.
⚠️ Avoid monotherapy with clindamycin or metronidazole alone. While clindamycin has good activity against staphylococci and anaerobes, it misses some gram-negative anaerobes. Metronidazole has excellent anaerobic coverage but no activity against aerobes 7.
⚠️ Consider the clinical context: If this culture is from a surgical site or area with prosthetic material, S. hominis should not be dismissed as a contaminant despite being "scanty" 2. Coagulase-negative staphylococci cause indolent infections around foreign material.
Duration and Adjunctive Measures
- Duration: Typically 7-14 days depending on clinical response and infection severity
- Surgical evaluation: Antimicrobial therapy alone may be insufficient 6, 5. Assess for need of drainage, debridement, or removal of foreign material
- Source control is paramount: Drainage of abscesses, debridement of necrotic tissue, and removal of infected prosthetic material when present are critical adjuncts to antimicrobial therapy 5
Clinical Monitoring
Monitor for clinical improvement within 48-72 hours. If signs of infection persist despite appropriate antibiotics, consider:
- Inadequate source control requiring surgical intervention
- Development of abscess requiring drainage
- Presence of foreign material requiring removal 2
- Need for anti-inflammatory supplementation in select cases (though this is not standard practice)
The combination of Gleimia europaea with other anaerobes suggests this may represent a more aggressive polymicrobial infection, as G. europaea has been specifically associated with necrotizing fasciitis 1, warranting close clinical monitoring and low threshold for imaging or surgical consultation.